31 results
DEF 14A
BEAM
Beam Therapeutics Inc
23 Apr 21
Definitive proxy
4:05pm
of Mr. Cooper and Ms. Walsh is an “audit committee financial expert,” as defined under Item 407 of Regulation S-K.
During the fiscal year ended December
10-K
ska 560on64j
30 Mar 20
Annual report
5:26pm
8-K
EX-3.2
x578 5u5m3
11 Feb 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
k4brr8mk9 xcky
7 Feb 20
Prospectus supplement with pricing info
12:00am
S-1/A
6daji01
17 Jan 20
IPO registration (amended)
4:09pm
S-1
EX-10.11
4ayw43 rw94sz8h
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.4
nyabv5gebhhu
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.5
qusd hbe065qnca7s00
27 Sep 19
IPO registration
4:34pm
S-1
6cqw9t3jhrx8l5tth
27 Sep 19
IPO registration
4:34pm
S-1
EX-3.3
srr2ehfrf 3j8tjrutv
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.6
leop9imqpn eb
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.7
n5riw80ihic0 it2zwh4
27 Sep 19
IPO registration
4:34pm
S-1
EX-10.9
p7f5xs vgno4w
27 Sep 19
IPO registration
4:34pm